Tyler Technologies
TYL
332.34
+1.43
+0.43%
Tyler Technologies
US · TYL
#1242 by market cap
Listed 1970
332.34
+1.43
+0.43%
Live - 5344 symbols - heartbeat 120s ago
· 2026-10-08 06:29
Pre-market
328.96
-1.02%
After-hours
332.34
0.00%
- Market cap
- 13.61B
- P/E (TTM)i
- 43.67
- P/Bi
- 4.48
- EPSi
- 7.20
- Div yieldi
- 0.00%
- 52W posi
- 24%
Reader sentiment
Are you bullish or bearish on TYL?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.40, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +9.10% YoY
Margins
- Gross margin
- 46.46%
- Operating margin
- 15.34%
- Net margin
- 13.53%
Key ratios & quality
- PEG ratioi
- 1.80
- Altman Z-Scorei
- 5.40
PEG uses trailing P/E against the 3-year net income growth rate (24.32%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 935.28M | 1.09B | 1.12B | 1.59B | 1.85B | 1.95B | 2.14B | 2.33B |
| Gross profit | 439.58M | 516.90M | 542.51M | 709.64M | 783.86M | 861.10M | 935.76M | 1.08B |
| Selling & admin expenses | 207.61M | 257.75M | 259.56M | 390.58M | 403.07M | 458.35M | 458.67M | 465.02M |
| Research & development | 63.26M | 81.34M | 88.36M | 93.48M | 105.18M | 109.59M | 117.94M | 204.59M |
| Operating profit | 152.49M | 156.37M | 172.93M | 180.74M | 214.25M | 218.54M | 299.53M | 357.68M |
| Pretax profit | 155.87M | 159.84M | 175.04M | 158.98M | 187.59M | 198.24M | 308.17M | 390.32M |
| Tax | 8.41M | 13.31M | -19.78M | -2.48M | 23.35M | 32.32M | 45.14M | 74.72M |
| Net profit | 147.46M | 146.53M | 194.82M | 161.46M | 164.24M | 165.92M | 263.03M | 315.60M |
| Basic EPS | 4 | 4 | 5 | 4 | 4 | 4 | 6 | 7 |
| Diluted EPS | 3.68 | 3.65 | 4.69 | 3.82 | 3.87 | 3.88 | 6.05 | 7.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 565.17M | 596.12M | 595.88M | 575.18M | 613.50M | 645.10M |
| Gross profit | 267.08M | 273.18M | 281.45M | 261.98M | 296.43M | 307.06M |
| Selling & admin expenses | 115.93M | 112.91M | 117.53M | 118.65M | 122.76M | 133.58M |
| Research & development | 47.84M | 50.84M | 51.79M | 54.11M | 59.73M | 62.83M |
| Operating profit | 89.17M | 95.60M | 97.93M | 74.98M | 99.81M | 95.10M |
| Pretax profit | 95.29M | 102.51M | 107.55M | 84.96M | 106.42M | 120.63M |
| Tax | 14.24M | 17.89M | 23.16M | 19.43M | 25.24M | 27.12M |
| Net profit | 81.05M | 84.63M | 84.39M | 65.53M | 81.18M | 93.51M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.84 | 1.93 | 1.93 | 1.50 | 1.88 | 2.23 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 518.86M | 679.70M | 1.11B | 964.33M | 847.24M | 860.59M | 1.44B | 1.84B |
| Cash & ST investments | 178.59M | 272.08M | 675.81M | 361.47M | 210.89M | 175.88M | 767.98M | 1.10B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.79B | 2.19B | 2.61B | 4.73B | 4.69B | 4.68B | 5.18B | 5.64B |
| Total current liabilities | 423.90M | 509.09M | 564.28M | 829.50M | 889.70M | 1.00B | 1.07B | 1.76B |
| Short-term debt | -- | 6.39M | 5.90M | 40.56M | 40.74M | 60.86M | 9.64M | 609.26M |
| Long-term debt | -- | -- | -- | 1.31B | 957.39M | 596.21M | 597.93M | -- |
| Total liabilities | 466,117,000.00 | 574,556,000.00 | 621,163,000.00 | 2,408,129,000.00 | 2,063,028,000.00 | 1,738,668,000.00 | 1,791,593,000.00 | 1,936,119,000.00 |
| Total equity | 1.32B | 1.62B | 1.99B | 2.32B | 2.62B | 2.94B | 3.39B | 3.70B |
| Retained earnings | 771.93M | 917.34M | 1.11B | 1.27B | 1.44B | 1.60B | 1.87B | 2.18B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.47B | 1.72B | 1.74B | 1.84B | 1.04B | 1.82B |
| Cash & ST investments | 807.40M | 892.35M | 950.82M | 1.10B | 346.35M | 970.04M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 5.19B | 5.43B | 5.46B | 5.64B | 4.80B | 5.81B |
| Total current liabilities | 1.56B | 1.67B | 1.69B | 1.76B | 1.04B | 1.17B |
| Short-term debt | 607.65M | 607.80M | 608.89M | 609.26M | 10.59M | 11.22M |
| Long-term debt | -- | -- | -- | -- | -- | 1.41B |
| Total liabilities | 1,679,430,000.00 | 1,791,088,000.00 | 1,854,602,000.00 | 1,936,119,000.00 | 1,240,386,000.00 | 2,776,345,000.00 |
| Total equity | 3.51B | 3.63B | 3.60B | 3.70B | 3.56B | 3.04B |
| Retained earnings | 1.95B | 2.03B | 2.12B | 2.18B | 2.26B | 2.36B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 250.20M | 254.72M | 355.09M | 371.75M | 381.46M | 380.44M | 624.63M | 653.54M |
| Depreciation & amortization | 61.76M | 76.67M | 81.66M | 145.84M | 172.04M | 170.77M | 152.37M | 147.86M |
| Free cash flow | 222.78M | 212.68M | 326.62M | 316.14M | 331.30M | 327.43M | 574.70M | 620.75M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -146.55M | -17.79M | -15.48M | -12.98M | -- | 0 | 0 | -174.65M |
| Ending cash balance | 134.28M | 232.68M | 603.62M | 309.17M | 173.86M | 165.49M | 744.72M | 1.02B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 56.16M | 98.31M | 255.19M | 243.88M | 107.26M | 124.41M |
| Depreciation & amortization | 36.91M | 36.89M | 37.29M | 36.77M | 41.27M | 39.38M |
| Free cash flow | 48.27M | 87.97M | 247.58M | 236.93M | 102.77M | 118.52M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | -1.61M | -173.05M | 0 | -250.06M | -504.94M |
| Ending cash balance | 705.73M | 787.45M | 834.10M | 1.02B | 316.01M | 895.35M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 11.84 | 9.96 | 10.81 | 7.49 | 6.64 | 5.97 | 8.32 | 8.90 |
| ROA %i | 8.72 | 7.36 | 8.12 | 4.40 | 3.49 | 3.54 | 5.34 | 5.83 |
| ROIC %i | 11.84 | 9.81 | 10.68 | 6.24 | 5.12 | 5.08 | 7.00 | 7.64 |
| 5-year avg ROE %i | 14.34 | 12.29 | 12.28 | 11.22 | 9.32 | 8.17 | 7.85 | 7.46 |
| EBIT margin %i | 16.30 | 14.39 | 15.49 | 11.45 | 11.67 | 11.37 | 14.69 | 16.95 |
| FCF / sales %i | 23.82 | 19.58 | 29.25 | 19.85 | 17.91 | 16.78 | 26.88 | 26.61 |
| Current ratioi | 1.22 | 1.34 | 1.97 | 1.16 | 0.95 | 0.86 | 1.35 | 1.05 |
| Quick ratioi | 1.14 | 1.28 | 1.91 | 1.09 | 0.89 | 0.79 | 1.28 | 1.00 |
| Debt / assetsi | 0.00 | 1.06 | 0.85 | 29.33 | 22.32 | 14.90 | 12.32 | 11.40 |
| LT debt / equityi | -- | 1.04 | 0.82 | 57.99 | 38.31 | 21.65 | 18.56 | 0.90 |
| Interest coveragei | -- | -- | -- | 7.82 | 7.61 | 9.39 | 52.96 | 79.14 |
| Revenue CAGR (3Y) %i | 16.53 | 12.66 | 9.92 | 19.41 | 19.42 | 20.46 | 10.32 | 8.03 |
| Net income CAGR (3Y) %i | 31.49 | 8.82 | 4.74 | 3.07 | 3.88 | -5.21 | 17.66 | 24.32 |
| FCF CAGR (3Y) %i | 22.29 | 11.33 | 28.85 | 12.37 | 15.92 | 0.08 | 22.04 | 23.28 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 8.87 | 9.07 | 9.17 | 8.90 | 8.93 | 9.73 |
| ROA %i | 5.92 | 5.99 | 6.03 | 5.83 | 6.32 | 5.78 |
| ROIC %i | 7.52 | 7.73 | 7.83 | 7.64 | 8.24 | 7.52 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 15.60 | 16.28 | 16.84 | 16.95 | 17.07 | 17.54 |
| FCF / sales %i | 25.83 | 26.95 | 26.10 | 26.61 | 28.36 | 29.05 |
| Current ratioi | 0.94 | 1.03 | 1.03 | 1.05 | 1.00 | 1.55 |
| Quick ratioi | 0.88 | 0.97 | 0.98 | 1.00 | 0.90 | 1.47 |
| Debt / assetsi | 12.33 | 11.83 | 11.79 | 11.40 | 1.00 | 25.03 |
| LT debt / equityi | 0.92 | 0.93 | 0.96 | 0.90 | 1.05 | 47.54 |
| Interest coveragei | 68.46 | 73.10 | 77.39 | 79.14 | 84.37 | 65.28 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Enterprise Software is the largest reported line at 73.84% of revenue, across 3 reported segments.
- The next-largest line, Platform Technologies, is a distant second at 24.94% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Enterprise Software73.84%
Platform Technologies24.94%
Revenues1.23%
Quote time 2026-10-08 06:29:58 · For reference only, not investment advice and not tailored to your situation.